Interventional Oncology
Etienne Garin, MD, PhD
Nuclear Medicine Physician
Université De Rennes 1/CRLCC Eugène Marquis
Disclosure(s): Boston Scientific: Advisory Committee/Board Member (), Consultant ()
Lambros Tselikas, MD, PhD
Attending
Gustave Roussy
Boris Guiu, MD, PhD
Chair, Radiology
St-Eloi University Hospital – Montpellier School of Medicine
Julia Chalaye, MD, PhD
not attending
Henry Mondor Hospital
Boris Campillo-Gimenez, MD
Methodologist
cancer Institute Eugène Marquis
after longer follow-up, personalized dosimetry maintained a meaningful improvement of OS. OS was dramatically improved for patients accurately down staged towards resection.